Effect of Genetic Variation of IL-13 on Airway Remodeling in Bronchial Asthma

IL-13 is a major stimulator of inflammation and tissue remodeling at sites of Th2 inflammation, and common single-nucleotide polymorphisms in IL13 are associated with allergic phenotypes in several ethnically diverse populations. In particular, IL13Q110 is the non-conservative replacement of a posit...

Full description

Saved in:
Bibliographic Details
Published inAllergology International Vol. 60; no. 3; pp. 291 - 298
Main Authors Nagashima, Hiromi, Nakamura, Yutaka, Kanno, Hiroyuki, Sawai, Takashi, Inoue, Hiroshi, Yamauchi, Kohei
Format Journal Article
LanguageEnglish
Published England Elsevier B.V 2011
JAPANESE SOCIETY OF ALLERGOLOGY
Elsevier
Subjects
Online AccessGet full text
ISSN1323-8930
1440-1592
1440-1592
DOI10.2332/allergolint.10-OA-0259

Cover

Abstract IL-13 is a major stimulator of inflammation and tissue remodeling at sites of Th2 inflammation, and common single-nucleotide polymorphisms in IL13 are associated with allergic phenotypes in several ethnically diverse populations. In particular, IL13Q110 is the non-conservative replacement of a positively charged arginine (R) with a neutral glutamine (Q) at position 110 of IL-13, and as we already know, individuals homozygous for glutamine (Q110/Q110) are strongly associated with asthma and IgE. IL13Q110 has been demonstrated to show that increased allergic inflammation depended on the enhanced IL-13-mediated Th2 effector function. Therefore, we investigated whether Q110/Q110 accelerated the decline in pulmonary function and development of airway remodeling of asthmatic patients in the general population. A total 336 asthmatic subjects living in Japan were recruited, genotyped, and had a pulmonary function test performed on them. To analyze airway inflammation and remodeling, bronchial lavage fluid (BLF) and endobronchial biopsy specimens were examined. Forced expiratory volume in one second (FEV1), %predicted, forced expiratory volume/forced vital capacity ratio, and forced expiratory flow 25-75%, % predicted were significantly decreased in Q110/Q110 compared to R110/R110, and the decline in FEV1 was increased significantly in Q110/Q110 compared to R 110/R110. The concentration of IL-13, IL-23, IL-11, GM-CSF, hyaluronic acid, and CCL8 in BLF were increased in Q110/Q110 compared to R110/R110 and the thickness of the subepithelial layer was thicker. Our study demonstrates that Q110/Q110 increases, at least in part, allergic inflammation and the propensity for airway remodeling, thus resulting in low lung function.
AbstractList Background: IL-13 is a major stimulator of inflammation and tissue remodeling at sites of Th2 inflammation, and common single-nucleotide polymorphisms in IL13 are associated with allergic phenotypes in several ethnically diverse populations. In particular, IL13Q110 is the non-conservative replacement of a positively charged arginine (R) with a neutral glutamine (Q) at position 110 of IL-13, and as we already know, individuals homozygous for glutamine (Q110/Q110) are strongly associated with asthma and IgE. IL13Q110 has been demonstrated to show that increased allergic inflammation depended on the enhanced IL-13-mediated Th2 effector function. Therefore, we investigated whether Q110/Q110 accelerated the decline in pulmonary function and development of airway remodeling of asthmatic patients in the general population. Methods: A total 336 asthmatic subjects living in Japan were recruited, genotyped, and had a pulmonary function test performed on them. To analyze airway inflammation and remodeling, bronchial lavage fluid (BLF) and endobronchial biopsy specimens were examined. Results: Forced expiratory volume in one second (FEV1), %predicted, forced expiratory volume/forced vital capacity ratio, and forced expiratory flow 25-75%, % predicted were significantly decreased in Q110/Q110 compared to R110/R110, and the decline in FEV1 was increased significantly in Q110/Q110 compared to R 110/R110. The concentration of IL-13, IL-23, IL-11, GM-CSF, hyaluronic acid, and CCL8 in BLF were increased in Q110/Q110 compared to R110/R110 and the thickness of the subepithelial layer was thicker. Conclusions: Our study demonstrates that Q110/Q110 increases, at least in part, allergic inflammation and the propensity for airway remodeling, thus resulting in low lung function.
IL-13 is a major stimulator of inflammation and tissue remodeling at sites of Th2 inflammation, and common single-nucleotide polymorphisms in IL13 are associated with allergic phenotypes in several ethnically diverse populations. In particular, IL13Q110 is the non-conservative replacement of a positively charged arginine (R) with a neutral glutamine (Q) at position 110 of IL-13, and as we already know, individuals homozygous for glutamine (Q110/Q110) are strongly associated with asthma and IgE. IL13Q110 has been demonstrated to show that increased allergic inflammation depended on the enhanced IL-13-mediated Th2 effector function. Therefore, we investigated whether Q110/Q110 accelerated the decline in pulmonary function and development of airway remodeling of asthmatic patients in the general population. A total 336 asthmatic subjects living in Japan were recruited, genotyped, and had a pulmonary function test performed on them. To analyze airway inflammation and remodeling, bronchial lavage fluid (BLF) and endobronchial biopsy specimens were examined. Forced expiratory volume in one second (FEV1), %predicted, forced expiratory volume/forced vital capacity ratio, and forced expiratory flow 25-75%, % predicted were significantly decreased in Q110/Q110 compared to R110/R110, and the decline in FEV1 was increased significantly in Q110/Q110 compared to R110/R110. The concentration of IL-13, IL-23, IL-11, GM-CSF, hyaluronic acid, and CCL8 in BLF were increased in Q110/Q110 compared to R110/R110 and the thickness of the subepithelial layer was thicker. Our study demonstrates that Q110/Q110 increases, at least in part, allergic inflammation and the propensity for airway remodeling, thus resulting in low lung function.
IL-13 is a major stimulator of inflammation and tissue remodeling at sites of Th2 inflammation, and common single-nucleotide polymorphisms in IL13 are associated with allergic phenotypes in several ethnically diverse populations. In particular, IL13Q110 is the non-conservative replacement of a positively charged arginine (R) with a neutral glutamine (Q) at position 110 of IL-13, and as we already know, individuals homozygous for glutamine (Q110/Q110) are strongly associated with asthma and IgE. IL13Q110 has been demonstrated to show that increased allergic inflammation depended on the enhanced IL-13-mediated Th2 effector function. Therefore, we investigated whether Q110/Q110 accelerated the decline in pulmonary function and development of airway remodeling of asthmatic patients in the general population.BACKGROUNDIL-13 is a major stimulator of inflammation and tissue remodeling at sites of Th2 inflammation, and common single-nucleotide polymorphisms in IL13 are associated with allergic phenotypes in several ethnically diverse populations. In particular, IL13Q110 is the non-conservative replacement of a positively charged arginine (R) with a neutral glutamine (Q) at position 110 of IL-13, and as we already know, individuals homozygous for glutamine (Q110/Q110) are strongly associated with asthma and IgE. IL13Q110 has been demonstrated to show that increased allergic inflammation depended on the enhanced IL-13-mediated Th2 effector function. Therefore, we investigated whether Q110/Q110 accelerated the decline in pulmonary function and development of airway remodeling of asthmatic patients in the general population.A total 336 asthmatic subjects living in Japan were recruited, genotyped, and had a pulmonary function test performed on them. To analyze airway inflammation and remodeling, bronchial lavage fluid (BLF) and endobronchial biopsy specimens were examined.METHODSA total 336 asthmatic subjects living in Japan were recruited, genotyped, and had a pulmonary function test performed on them. To analyze airway inflammation and remodeling, bronchial lavage fluid (BLF) and endobronchial biopsy specimens were examined.Forced expiratory volume in one second (FEV1), %predicted, forced expiratory volume/forced vital capacity ratio, and forced expiratory flow 25-75%, % predicted were significantly decreased in Q110/Q110 compared to R110/R110, and the decline in FEV1 was increased significantly in Q110/Q110 compared to R110/R110. The concentration of IL-13, IL-23, IL-11, GM-CSF, hyaluronic acid, and CCL8 in BLF were increased in Q110/Q110 compared to R110/R110 and the thickness of the subepithelial layer was thicker.RESULTSForced expiratory volume in one second (FEV1), %predicted, forced expiratory volume/forced vital capacity ratio, and forced expiratory flow 25-75%, % predicted were significantly decreased in Q110/Q110 compared to R110/R110, and the decline in FEV1 was increased significantly in Q110/Q110 compared to R110/R110. The concentration of IL-13, IL-23, IL-11, GM-CSF, hyaluronic acid, and CCL8 in BLF were increased in Q110/Q110 compared to R110/R110 and the thickness of the subepithelial layer was thicker.Our study demonstrates that Q110/Q110 increases, at least in part, allergic inflammation and the propensity for airway remodeling, thus resulting in low lung function.CONCLUSIONSOur study demonstrates that Q110/Q110 increases, at least in part, allergic inflammation and the propensity for airway remodeling, thus resulting in low lung function.
[ABSTRACT] Background: IL-13 is a major stimulator of inflammation and tissue remodeling at sites of Th2 inflammation, and common single-nucleotide polymorphisms in IL13 are associated with allergic phenotypes in several ethnically diverse populations. In particular, IL13Q110 is the non-conservative replacement of a positively charged arginine (R) with a neutral glutamine (Q) at position 110 of IL-13, and as we already know, individuals homozygous for glutamine (Q110/Q110) are strongly associated with asthma and IgE. IL13Q110 has been demonstrated to show that increased allergic inflammation depended on the enhanced IL-13-mediated Th2 effector function. Therefore, we investigated whether Q110/Q110 accelerated the decline in pulmonary function and development of airway remodeling of asthmatic patients in the general population. Methods: A total 336 asthmatic subjects living in Japan were recruited, genotyped, and had a pulmonary function test performed on them. To analyze airway inflammation and remodeling, bronchial lavage fluid (BLF) and endobronchial biopsy specimens were examined. Results: Forced expiratory volume in one second (FEV1), %predicted, forced expiratory volume/forced vital capacity ratio, and forced expiratory flow 25-75%, % predicted were significantly decreased in Q110/Q110 compared to R110/R110, and the decline in FEV1 was increased significantly in Q110/Q110 compared to R110/R110. The concentration of IL-13, IL-23, IL-11, GM-CSF, hyaluronic acid, and CCL8 in BLF were increased in Q110/Q110 compared to R110/R110 and the thickness of the subepithelial layer was thicker. Conclusions: Our study demonstrates that Q110/Q110 increases, at least in part, allergic inflammation and the propensity for airway remodeling, thus resulting in low lung function.
IL-13 is a major stimulator of inflammation and tissue remodeling at sites of Th2 inflammation, and common single-nucleotide polymorphisms in IL13 are associated with allergic phenotypes in several ethnically diverse populations. In particular, IL13Q110 is the non-conservative replacement of a positively charged arginine (R) with a neutral glutamine (Q) at position 110 of IL-13, and as we already know, individuals homozygous for glutamine (Q110/Q110) are strongly associated with asthma and IgE. IL13Q110 has been demonstrated to show that increased allergic inflammation depended on the enhanced IL-13-mediated Th2 effector function. Therefore, we investigated whether Q110/Q110 accelerated the decline in pulmonary function and development of airway remodeling of asthmatic patients in the general population. A total 336 asthmatic subjects living in Japan were recruited, genotyped, and had a pulmonary function test performed on them. To analyze airway inflammation and remodeling, bronchial lavage fluid (BLF) and endobronchial biopsy specimens were examined. Forced expiratory volume in one second (FEV1), %predicted, forced expiratory volume/forced vital capacity ratio, and forced expiratory flow 25-75%, % predicted were significantly decreased in Q110/Q110 compared to R110/R110, and the decline in FEV1 was increased significantly in Q110/Q110 compared to R 110/R110. The concentration of IL-13, IL-23, IL-11, GM-CSF, hyaluronic acid, and CCL8 in BLF were increased in Q110/Q110 compared to R110/R110 and the thickness of the subepithelial layer was thicker. Our study demonstrates that Q110/Q110 increases, at least in part, allergic inflammation and the propensity for airway remodeling, thus resulting in low lung function.
Author Sawai, Takashi
Yamauchi, Kohei
Nakamura, Yutaka
Inoue, Hiroshi
Nagashima, Hiromi
Kanno, Hiroyuki
Author_xml – sequence: 1
  givenname: Hiromi
  surname: Nagashima
  fullname: Nagashima, Hiromi
  email: ICB75097@nifty.com
  organization: Division of Pulmonary Medicine, Allergy, and Rheumatology, Department of Internal Medicine,Iwate, Japan
– sequence: 2
  givenname: Yutaka
  surname: Nakamura
  fullname: Nakamura, Yutaka
  organization: Division of Pulmonary Medicine, Allergy, and Rheumatology, Department of Internal Medicine,Iwate, Japan
– sequence: 3
  givenname: Hiroyuki
  surname: Kanno
  fullname: Kanno, Hiroyuki
  organization: Division of Leading Pathophysiology, Department of Pathology, Iwate Medical University School of Medicine,Iwate, Japan
– sequence: 4
  givenname: Takashi
  surname: Sawai
  fullname: Sawai, Takashi
  organization: Division of Leading Pathophysiology, Department of Pathology, Iwate Medical University School of Medicine,Iwate, Japan
– sequence: 5
  givenname: Hiroshi
  surname: Inoue
  fullname: Inoue, Hiroshi
  organization: Iwate Red Cross Blood Center, Iwate, Japan
– sequence: 6
  givenname: Kohei
  surname: Yamauchi
  fullname: Yamauchi, Kohei
  organization: Division of Pulmonary Medicine, Allergy, and Rheumatology, Department of Internal Medicine,Iwate, Japan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/21430433$$D View this record in MEDLINE/PubMed
BookMark eNqFUk1v1DAQjVAR_YC_UOXGKWXsSRxb4sBSlWWlRSsh4Go5zmTrVdYuTrZV_z3OplSISy-e0fi9N-N5Ps9OfPCUZZcMrjgi_2D6nuI29M6PVwyKzaIAXqlX2RkrSyhYpfhJypFjIRXCaXY-DDsAxmtVv8lOOSsRSsSz7NtN15Ed89DlS_I0Opv_MtGZ0QU_FVfrgmGe8oWLD-Yx_0770FJqu82dzz_H4O2tM32-GMbbvXmbve5MP9C7p3iR_fxy8-P6a7HeLFfXi3VhhapUUZLCRgKzAutOpLkZs5wstgRkLAITZcdZ03SykhYr0bESbLqoFW9rJTheZKtZtw1mp--i25v4qINx-lgIcatNTG_pSTdM2LbhoGRtygqbRkhE0dUSmYDW1Enr_ax1F8PvAw2j3rvBUt8bT-EwaCkrrgBKmZCXT8hDs6f2ue_fbSaAmAE2hmGI1D1DGOjJNv2PbVNts9CTbYn48T-idePRgzEa179MX870NJWzpg8-IUjvwiH6ZIO2D6U5cjgwpgEEAKYgE1ux6ZCsQgYwLfbTrETJvXtHUQ_WkbdJN6ZvktbrXhrmD0UOzMw
CitedBy_id crossref_primary_10_1016_j_jbiomech_2016_12_002
crossref_primary_10_3389_falgy_2024_1365801
crossref_primary_10_1371_journal_pone_0188407
crossref_primary_10_1111_crj_12647
crossref_primary_10_1016_j_resinv_2013_02_003
crossref_primary_10_1186_s12931_023_02528_w
crossref_primary_10_1016_j_alit_2015_01_001
crossref_primary_10_1016_j_bbadis_2020_165950
crossref_primary_10_3389_fimmu_2017_01172
crossref_primary_10_1111_cea_12710
crossref_primary_10_2332_allergolint_12_OA_0528
crossref_primary_10_1016_j_intimp_2015_08_043
crossref_primary_10_1016_j_smim_2019_101346
crossref_primary_10_4168_aair_2019_11_5_604
Cites_doi 10.1164/ajrccm.151.6.7767540
10.1067/mai.2002.124656
10.1172/JCI200522818
10.1016/j.jaci.2003.10.044
10.1093/hmg/9.4.549
10.1067/mai.2000.107935
10.4049/jimmunol.174.4.2305
10.1016/S0091-6749(98)70018-1
10.1172/JCI17748
10.4049/jimmunol.177.12.8633
10.1056/NEJM200010123431501
10.1165/rcmb.2002-0009OC
10.1164/ajrccm/140.6.1745
10.1136/thx.53.1.21
10.1016/j.rmed.2005.02.027
10.1016/j.jaci.2008.02.029
10.1164/rccm.200801-086OC
10.1164/ajrccm.160.2.9809040
10.1016/S0140-6736(89)90067-6
10.1183/09031936.03.00082002
10.1067/mai.2001.115626
10.1046/j.1365-2222.1998.00277.x
10.1164/ajrccm.156.2.9609066
10.1016/S0091-6749(00)90070-8
10.1016/j.jaci.2005.12.1354
10.1136/thx.53.10.835
10.1038/sj.gene.6363896
10.1016/0091-6749(91)90408-G
10.1067/mai.2000.104940
ContentType Journal Article
Copyright 2011 Japanese Society of Allergology
Copyright_xml – notice: 2011 Japanese Society of Allergology
CorporateAuthor Allergy
Department of Pathology
Department of Internal Medicine
Iwate Red Cross Blood Center
Division of Leading Pathophysiology
Division of Pulmonary Medicine
Iwate Medical University School of Medicine
and Rheumatology
CorporateAuthor_xml – name: Department of Pathology
– name: Allergy
– name: Division of Leading Pathophysiology
– name: Division of Pulmonary Medicine
– name: and Rheumatology
– name: Iwate Medical University School of Medicine
– name: Iwate Red Cross Blood Center
– name: Department of Internal Medicine
DBID 6I.
AAFTH
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOA
DOI 10.2332/allergolint.10-OA-0259
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE
MEDLINE - Academic


Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1440-1592
EndPage 298
ExternalDocumentID oai_doaj_org_article_b16cdb20987a453bb68336f783160da7
21430433
10_2332_allergolint_10_OA_0259
cw4alint_2011_006003_008_0291_02981531002
S132389301530530X
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
.55
0R~
0SF
1OC
23M
2WC
31~
4.4
457
53G
5GY
5VS
6I.
7.U
8-1
AACTN
AAEDW
AAFTH
AAIKJ
AALRI
AAXUO
ABMAC
ACGFO
ACGFS
ACXQS
ADBBV
ADEZE
AENEX
AEXQZ
AFTJW
AFZJQ
AGHFR
AHPSJ
AITUG
AJAOE
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
AZFZN
BAWUL
BCNDV
BFHJK
CAG
CO8
COF
CS3
DIK
E3Z
EBS
EJD
F5P
FDB
FRJ
GROUPED_DOAJ
GX1
HZ~
IPNFZ
JSF
JSH
KQ8
LH4
LW6
M41
NCXOZ
O9-
OK1
P2P
P6G
RIG
RJT
RNS
ROL
RZJ
SSZ
TKC
TR2
X7M
YFH
YUY
AAYWO
ACVFH
ADCNI
ADVLN
AEUPX
AFPUW
AIGII
AKBMS
AKRWK
AKYEP
OVT
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c6959-4e93b801c637f625911c2ec3de0eac30164f21bbf858c356f140cac3792d79623
IEDL.DBID DOA
ISSN 1323-8930
1440-1592
IngestDate Wed Aug 27 01:17:07 EDT 2025
Thu Jul 10 17:11:10 EDT 2025
Thu Jan 02 22:10:21 EST 2025
Tue Jul 01 04:11:24 EDT 2025
Thu Apr 24 22:53:43 EDT 2025
Thu Jul 10 16:16:36 EDT 2025
Fri Feb 23 02:29:20 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords bronchial asthma
bronchial lavage fluid
IL-13
polymorphisms
bronchial biopsy
Language English
License http://creativecommons.org/licenses/by-nc-nd/4.0
http://www.elsevier.com/tdm/userlicense/1.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c6959-4e93b801c637f625911c2ec3de0eac30164f21bbf858c356f140cac3792d79623
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://doaj.org/article/b16cdb20987a453bb68336f783160da7
PMID 21430433
PQID 885290048
PQPubID 23479
PageCount 8
ParticipantIDs doaj_primary_oai_doaj_org_article_b16cdb20987a453bb68336f783160da7
proquest_miscellaneous_885290048
pubmed_primary_21430433
crossref_primary_10_2332_allergolint_10_OA_0259
crossref_citationtrail_10_2332_allergolint_10_OA_0259
medicalonline_journals_cw4alint_2011_006003_008_0291_02981531002
elsevier_sciencedirect_doi_10_2332_allergolint_10_OA_0259
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2011-00-00
PublicationDateYYYYMMDD 2011-01-01
PublicationDate_xml – year: 2011
  text: 2011-00-00
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Allergology International
PublicationTitleAlternate Allergol Int
PublicationYear 2011
Publisher Elsevier B.V
JAPANESE SOCIETY OF ALLERGOLOGY
Elsevier
Publisher_xml – name: Elsevier B.V
– name: JAPANESE SOCIETY OF ALLERGOLOGY
– name: Elsevier
References Belperio (10.2332/allergolint.10-OA-0259_bb0040) 2002; 27
Liu (10.2332/allergolint.10-OA-0259_bb0110) 2000; 106
The Childhood Asthma Management Program Research Group (10.2332/allergolint.10-OA-0259_bb0150) 2000; 343
Hoshino (10.2332/allergolint.10-OA-0259_bb0020) 2001; 107
Hoffjan (10.2332/allergolint.10-OA-0259_bb0050) 2004; 113
Nakamura (10.2332/allergolint.10-OA-0259_bb0080) 1998; 53
Hoshino (10.2332/allergolint.10-OA-0259_bb0010) 1998; 53
Roche (10.2332/allergolint.10-OA-0259_bb0025) 1989; 1
Vignola (10.2332/allergolint.10-OA-0259_bb0090) 1997; 156
Hoshino (10.2332/allergolint.10-OA-0259_bb0100) 1998; 28
Elias (10.2332/allergolint.10-OA-0259_bb0035) 2003; 111
Kay (10.2332/allergolint.10-OA-0259_bb0005) 1991; 87
Wakashin (10.2332/allergolint.10-OA-0259_bb0125) 2008; 178
Vladich (10.2332/allergolint.10-OA-0259_bb0120) 2005; 115
van der Pouw Kraan (10.2332/allergolint.10-OA-0259_bb0045) 2002; 3
Takishima (10.2332/allergolint.10-OA-0259_bb0075) 1981; 80
Busse (10.2332/allergolint.10-OA-0259_bb0145) 2008; 121
Minshall (10.2332/allergolint.10-OA-0259_bb0130) 2000; 105
Hoshino (10.2332/allergolint.10-OA-0259_bb0095) 1998; 102
Jeffery (10.2332/allergolint.10-OA-0259_bb0030) 1989; 140
Cameron (10.2332/allergolint.10-OA-0259_bb0055) 2006; 177
Maier (10.2332/allergolint.10-OA-0259_bb0060) 2006; 117
Huang (10.2332/allergolint.10-OA-0259_bb0015) 1999; 160
Arima (10.2332/allergolint.10-OA-0259_bb0070) 2002; 109
Takahashi (10.2332/allergolint.10-OA-0259_bb0085) 2005; 99
Woolley (10.2332/allergolint.10-OA-0259_bb0140) 1995; 151
Graves (10.2332/allergolint.10-OA-0259_bb0115) 2000; 105
Heinzmann (10.2332/allergolint.10-OA-0259_bb0065) 2000; 9
Chen (10.2332/allergolint.10-OA-0259_bb0135) 2005; 174
Hoshino (10.2332/allergolint.10-OA-0259_bb0105) 2003; 21
References_xml – volume: 151
  start-page: 1915
  year: 1995
  ident: 10.2332/allergolint.10-OA-0259_bb0140
  article-title: Effects of allergen challenge on eosinophils, eosinophil cationic protein, and granulocyte-macrophage colony-stimulating factor in mild asthma
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/ajrccm.151.6.7767540
– volume: 109
  start-page: 980
  year: 2002
  ident: 10.2332/allergolint.10-OA-0259_bb0070
  article-title: Upregulation of IL-13 concentration in vivo by the IL13 variant associated with bronchial asthma
  publication-title: J Allergy Clin Immunol
  doi: 10.1067/mai.2002.124656
– volume: 80
  start-page: 600
  year: 1981
  ident: 10.2332/allergolint.10-OA-0259_bb0075
  article-title: Direct-writing recorder of the dose–response curves of the airway to methacholine
  publication-title: Clinical application. Chest
– volume: 115
  start-page: 747
  year: 2005
  ident: 10.2332/allergolint.10-OA-0259_bb0120
  article-title: IL-13R130Q, a common variant associated with allergy and asthma, enhances effector mechanisms essential for human allergic inflammation
  publication-title: J Clin Invest
  doi: 10.1172/JCI200522818
– volume: 113
  start-page: 511
  year: 2004
  ident: 10.2332/allergolint.10-OA-0259_bb0050
  article-title: Genetic variation in immunoregulatory pathways and atopic phenotypes in infancy
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2003.10.044
– volume: 9
  start-page: 549
  year: 2000
  ident: 10.2332/allergolint.10-OA-0259_bb0065
  article-title: Genetic variants of IL-13 signalling and human asthma and atopy
  publication-title: Hum Mol Genet
  doi: 10.1093/hmg/9.4.549
– volume: 106
  start-page: 167
  year: 2000
  ident: 10.2332/allergolint.10-OA-0259_bb0110
  article-title: An IL-13 coding region variant is associated with a high total serum IgE level and atopic dermatitis in the German multicenter atopy study (MAS-90)
  publication-title: J Allergy Clin Immunol
  doi: 10.1067/mai.2000.107935
– volume: 174
  start-page: 2305
  year: 2005
  ident: 10.2332/allergolint.10-OA-0259_bb0135
  article-title: IL-11 receptor alpha in the pathogenesis of IL-13-induced inflammation and remodeling
  publication-title: J Immunol
  doi: 10.4049/jimmunol.174.4.2305
– volume: 102
  start-page: 783
  year: 1998
  ident: 10.2332/allergolint.10-OA-0259_bb0095
  article-title: Bronchial subepithelial fibrosis and expression of matrix metalloproteinsas-9 in asthmatic airway inflammation
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/S0091-6749(98)70018-1
– volume: 111
  start-page: 291
  year: 2003
  ident: 10.2332/allergolint.10-OA-0259_bb0035
  article-title: New insights into the pathogenesis of asthma
  publication-title: J Clin Invest
  doi: 10.1172/JCI17748
– volume: 177
  start-page: 8633
  year: 2006
  ident: 10.2332/allergolint.10-OA-0259_bb0055
  article-title: Th2 cell-selective enhancement of human IL13 transcription by IL 13-1112C>T, a polymorphism associated with allergic inflammation
  publication-title: J Immunol
  doi: 10.4049/jimmunol.177.12.8633
– volume: 343
  start-page: 1054
  year: 2000
  ident: 10.2332/allergolint.10-OA-0259_bb0150
  article-title: Long-term effects of budesonide or nedocromil in children with asthma
  publication-title: N Engl J Med
  doi: 10.1056/NEJM200010123431501
– volume: 27
  start-page: 419
  year: 2002
  ident: 10.2332/allergolint.10-OA-0259_bb0040
  article-title: Interaction of IL-13 and C10 in the pathogenesis of bleomycin-induced pulmonary fibrosis
  publication-title: Am J Respir Cell Mol Biol
  doi: 10.1165/rcmb.2002-0009OC
– volume: 140
  start-page: 1745
  year: 1989
  ident: 10.2332/allergolint.10-OA-0259_bb0030
  article-title: Bronchial biopsies in asthma. An ultrastructural, quantitative study and correlation with hyperreactivity
  publication-title: Am Rev Respir Dis
  doi: 10.1164/ajrccm/140.6.1745
– volume: 53
  start-page: 21
  year: 1998
  ident: 10.2332/allergolint.10-OA-0259_bb0010
  article-title: Expression of growth factors and remodelling of the airway wall in bronchial asthma
  publication-title: Thorax
  doi: 10.1136/thx.53.1.21
– volume: 99
  start-page: 1125
  year: 2005
  ident: 10.2332/allergolint.10-OA-0259_bb0085
  article-title: Essential roles of angiotensin II in vascular endothelial growth factor expression in sleep apnea syndrome
  publication-title: Respir Med
  doi: 10.1016/j.rmed.2005.02.027
– volume: 121
  start-page: 1167
  year: 2008
  ident: 10.2332/allergolint.10-OA-0259_bb0145
  article-title: The Inhaled steroid treatment as regular therapy in early asthma (START) study 5-year follow-up: effectiveness of early intervention with budesonide in mild persistent asthma
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2008.02.029
– volume: 178
  start-page: 1023
  year: 2008
  ident: 10.2332/allergolint.10-OA-0259_bb0125
  article-title: IL-23 and Th17 cells enhance Th2-cell-mediated eosinophilic airway inflammation in mice
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.200801-086OC
– volume: 160
  start-page: 725
  year: 1999
  ident: 10.2332/allergolint.10-OA-0259_bb0015
  article-title: Enhanced proteoglycan deposition in the airway wall of atopic asthmatics
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/ajrccm.160.2.9809040
– volume: 1
  start-page: 520
  year: 1989
  ident: 10.2332/allergolint.10-OA-0259_bb0025
  article-title: Subepithelial fibrosis in the bronchi of asthmatics
  publication-title: Lancet
  doi: 10.1016/S0140-6736(89)90067-6
– volume: 21
  start-page: 804
  year: 2003
  ident: 10.2332/allergolint.10-OA-0259_bb0105
  article-title: Increased immunoreactivity of stromal cell-derived factor-1 and angiogenesis in asthma
  publication-title: Eur Respir J
  doi: 10.1183/09031936.03.00082002
– volume: 107
  start-page: 1034
  year: 2001
  ident: 10.2332/allergolint.10-OA-0259_bb0020
  article-title: Gene expression of vascular endothelial growth factor and its receptors and angiogenesis in bronchial asthma
  publication-title: J Allergy Clin Immunol
  doi: 10.1067/mai.2001.115626
– volume: 28
  start-page: 568
  year: 1998
  ident: 10.2332/allergolint.10-OA-0259_bb0100
  article-title: Inhaled corticosteroid reduced lamina reticularis of the basement membrane by modulation of insulin-like growth factor (IGF)-I expression in bronchial asthma
  publication-title: Clin Exp Allergy
  doi: 10.1046/j.1365-2222.1998.00277.x
– volume: 156
  start-page: 591
  year: 1997
  ident: 10.2332/allergolint.10-OA-0259_bb0090
  article-title: Transforming growth factor-beta expression in mucosal biopsies in asthma and chronic bronchitis
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/ajrccm.156.2.9609066
– volume: 105
  start-page: 232
  year: 2000
  ident: 10.2332/allergolint.10-OA-0259_bb0130
  article-title: IL-11 expression is increased is severe asthma: association with epithelial cells and eosinophils
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/S0091-6749(00)90070-8
– volume: 117
  start-page: 1306
  year: 2006
  ident: 10.2332/allergolint.10-OA-0259_bb0060
  article-title: Association of IL 13 with total IgE: evidence against an inverse association of atopy and diabetes
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2005.12.1354
– volume: 53
  start-page: 835
  year: 1998
  ident: 10.2332/allergolint.10-OA-0259_bb0080
  article-title: Effect of the leukotriene receptor antagonist pranlukast on cellular infiltration in the bronchial mucosa of patients with asthma
  publication-title: Thorax
  doi: 10.1136/thx.53.10.835
– volume: 3
  start-page: 436
  year: 2002
  ident: 10.2332/allergolint.10-OA-0259_bb0045
  article-title: Chronic obstructive pulmonary disease is associated with the −1055 IL-13 promoter polymorphism
  publication-title: Genes Immun
  doi: 10.1038/sj.gene.6363896
– volume: 87
  start-page: 893
  year: 1991
  ident: 10.2332/allergolint.10-OA-0259_bb0005
  article-title: Asthma and inflammation
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/0091-6749(91)90408-G
– volume: 105
  start-page: 506
  year: 2000
  ident: 10.2332/allergolint.10-OA-0259_bb0115
  article-title: A cluster of seven tightly linked polymorphisms in the IL-13 gene is associated with total serum IgE levels in three populations of white children
  publication-title: J Allergy Clin Immunol
  doi: 10.1067/mai.2000.104940
SSID ssj0012797
ssib044728993
ssib050995378
ssib001508366
Score 1.9458914
Snippet IL-13 is a major stimulator of inflammation and tissue remodeling at sites of Th2 inflammation, and common single-nucleotide polymorphisms in IL13 are...
[ABSTRACT] Background: IL-13 is a major stimulator of inflammation and tissue remodeling at sites of Th2 inflammation, and common single-nucleotide...
Background: IL-13 is a major stimulator of inflammation and tissue remodeling at sites of Th2 inflammation, and common single-nucleotide polymorphisms in IL13...
SourceID doaj
proquest
pubmed
crossref
medicalonline
elsevier
SourceType Open Website
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 291
SubjectTerms Adult
Aged
Airway Remodeling - genetics
Asthma - genetics
Asthma - immunology
Asthma - pathology
bronchial asthma
bronchial biopsy
bronchial lavage fluid
Bronchoalveolar Lavage Fluid - chemistry
Bronchoalveolar Lavage Fluid - immunology
Female
Fibroblasts - metabolism
Gene Expression Profiling
Genetic Predisposition to Disease
Genetic Variation
Genotype
Humans
IL-13
Inflammation Mediators - metabolism
Interleukin-13 - genetics
Male
Middle Aged
polymorphisms
Respiratory Mucosa - pathology
Title Effect of Genetic Variation of IL-13 on Airway Remodeling in Bronchial Asthma
URI https://dx.doi.org/10.2332/allergolint.10-OA-0259
http://mol.medicalonline.jp/library/journal/abstract?GoodsID=cw4alint/2011/006003/008&name=0291-0298e
https://www.ncbi.nlm.nih.gov/pubmed/21430433
https://www.proquest.com/docview/885290048
https://doaj.org/article/b16cdb20987a453bb68336f783160da7
Volume 60
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3di9QwEA9ygggifttTjzz4GjZN0iZ5uyp3nJ7rweHpvYUkTXXB68ruHocv_u3ONN3l9kH2RSihpOnXZNL5TZP5DSFvjTTaVEoxqYRiKrWCeRFLFpXVyfOO84CBwtPP9cmF-nhZXd5K9YVrwjI9cBbcJJR1bIPg4Bt7VckQaiNl3Wkjy5q3fogj55avnalx_kDonFZFCsnAIvMcGyykFBNMUbL4jhlxkD2anTUMzL7dMksDe_-WdXpwladNMn3Fv9HoYJWOH5GHI5ykTX6Nx-RO6p-Qe9NxwvwpmWZ2YjrvKBJMQyv6FbzjoTuw8sMnVkoK-81sceN_0_M0pMYBe0ZnPQUfvce10HCD5erHlX9GLo6Pvrw_YWMGBRZr_L-nkpUBbFCspe7Q0ynLKFKUbeLwwZVIr9WJMoTOVCbKqu7A3YpwQFvRagvI6DnZ6-d9ekmo1Rg0K7XmbauCrL2MURmMMvSAMpIvSLUWoIsjvThmufjpwM1Awbtbgse6s8ah4Asy2Zz3KxNs7DzjHfbPpjUSZA8VoDZuVBu3S20KYte960askTEEXGq28wEOt9TBjcN-6eKN8kNjhFUOuW64dEOeT2FLLAwYGCS9LQhda5CD8YyTNL5P8-ulM6YSFr-rBXmRNWvzogKwLfLN7f8PAbwi9_Pvcdxek73V4jq9AXy1CgfkbnN6_u30YBhSUE7_HP0FoeYflg
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effect+of+Genetic+Variation+of+IL-13+on+Airway+Remodeling+in+Bronchial+Asthma&rft.jtitle=Allergology+international&rft.au=Nagashima%2C+Hiromi&rft.au=Nakamura%2C+Yutaka&rft.au=Kanno%2C+Hiroyuki&rft.au=Sawai%2C+Takashi&rft.date=2011&rft.pub=Elsevier+B.V&rft.issn=1323-8930&rft.eissn=1440-1592&rft.volume=60&rft.issue=3&rft.spage=291&rft.epage=298&rft_id=info:doi/10.2332%2Fallergolint.10-OA-0259&rft.externalDocID=S132389301530530X
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1323-8930&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1323-8930&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1323-8930&client=summon